Many factors determine the best fertility or hormonal preservation option for each patient. In this article, fertility specialist Laura Detti, MD, and gynecologic oncologist Robert DeBernardo, MD, discuss their approach to fertility preservation for women facing surgery for endometriosis or gynecologic cancer.
Combining minimally invasive interval debulking surgery with the life-extending benefits of hyperthermic intraperitoneal chemotherapy for appropriate candidates with epithelial ovarian cancer that has spread to the abdominal cavity. In this article, Chad Michener, MD, explains the minimally invasive technique.
Early recovery after surgery pathways, coupled with interventions to decrease wound infections, lead to better pain management and fewer complications for patients following surgery for gynecologic malignancy. Surgeons Robert DeBernardo, MD, and Roberto Vargas, MD, discuss the development and implementation of these procedures.
Delayed time-to-surgery has a negative impact on overall survival of women with early stage endometrial cancer, a recent study reveals. Contributors to delay include race, insurance status and facility type. Additional contributors may include increased frequency of preoperative diagnostic testing, individual surgeon case load, lack of surgeon access to a robotic surgery platform, or availability of specialist gynecologic oncologists.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Many patients with ovarian cancer receive aggressive care at the end of their lives. Gynecologic oncologist, Chad Michener, MD, presents preliminary data from research into barriers to timely palliative and hospice care referrals, as perceived by physicians.
The Cleveland Clinic Center for Research Excellence in Gynecologic Cancer (CREGC) is a collaborative network for the development of a comprehensive research program to promote the translation of basic science investigation into the clinic.
Feasibility study will determine how augmented reality assessment compares to the current model of minimally invasive evaluation and the standard-of-care conventional surgery for ovarian cancer.